Evidence map›Paper›PMID 21957234›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2011

Synaptic and extrasynaptic NMDA receptors differentially modulate neuronal cyclooxygenase-2 function, lipid peroxidation, and neuroprotection.

David T Stark, Nicolas G Bazan

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 75 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Unveiling the Therapeutic Potential ofBioMed research international · 2025
    Article
  6. Article
  7. Tonic Activation of NR2D-Containing NMDARs Exacerbates Dopaminergic Neuronal Loss in MPTP-Injected Parkinsonian Mice.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

David T StarkNeuroscience Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, Louisiana 70112, USA.
Nicolas G Bazan
Louisiana State University Health Sciences Center New Orleans · US

Funding

SYNAPTIC AND EXTRASYNAPTIC NMDA RECEPTORS AND NEUROPROTECTIVE LIPID SIGNALINGP20RR016816 · NCRR · LSU HEALTH SCIENCES CENTER · PI INGLIS, FIONA M · 2002 to 2011
$20.2M
Neuroprotection Lipid Signaling in Ischemia ReperfusionR01NS046741 · NINDS · LSU HEALTH SCIENCES CENTER · PI BAZAN, NICOLAS G. · 2004 to 2014
$3.4M
Mechanism of action of omega-3 fatty acids in brain injuryRC2AT005909 · NCCIH · LSU HEALTH SCIENCES CENTER · PI BAZAN, NICOLAS G., PETASIS, NICOS A · 2009 to 2010
$2.8M
Regulation of Neuroprotective Lipid Sgnals by Spatially Distinct NMDA ReceptorsF30NS063630 · NINDS · LSU HEALTH SCIENCES CENTER · PI STARK, DAVID THOMS · 2009 to 2013
$125k
NCCIH NIH HHS RC2 AT005909NCRR NIH HHS P20 RR016816NINDS NIH HHS F30 NS063630NINDS NIH HHS NS063630NINDS NIH HHS R01 NS046741
6 · The paper itself

Abstract

Stimulation of synaptic NMDA receptors (NMDARs) induces neuroprotection, while extrasynaptic NMDARs promote excitotoxic cell death. Neuronal expression of cyclooxygenase-2 (COX-2) is enhanced by synaptic NMDARs, and although this enzyme mediates neuronal functions, COX-2 is also regarded as a key modulator of neuroinflammation and is thought to exacerbate excitotoxicity via overproduction of prostaglandins. This raises an apparent paradox: synaptic NMDARs are pro-survival yet are essential for robust neuronal COX-2 expression. We hypothesized that stimulation of extrasynaptic NMDARs converts COX-2 signaling from a physiological to a potentially pathological process. We combined HPLC-electrospray ionization-tandem MS-based mediator lipidomics and unbiased image analysis in mouse dissociated and organotypic cortical cultures to uncover that synaptic and extrasynaptic NMDARs differentially modulate neuronal COX-2 expression and activity. We show that synaptic NMDARs enhance neuronal COX-2 expression, while sustained synaptic stimulation limits COX-2 activity by suppressing cellular levels of the primary COX-2 substrate, arachidonic acid (AA). In contrast, extrasynaptic NMDARs suppress COX-2 expression while activating phospholipase A₂, which enhances AA levels by hydrolysis of membrane phospholipids. Thus, sequential activation of synaptic then extrasynaptic NMDARs maximizes COX-2-dependent prostaglandin synthesis. We also show that excitotoxic events only drive induction of COX-2 expression through abnormal synaptic network excitability. Finally, we show that nonenzymatic lipid peroxidation of arachidonic and other polyunsaturated fatty acids is a function of network activity history. A new paradigm emerges from our results suggesting that pathological COX-2 signaling associated with models of stroke, epilepsy, and neurodegeneration requires specific spatiotemporal NMDAR stimulation.

Indexed as

AnimalsAnimals, NewbornCells, CulturedCyclooxygenase 2FemaleLipid PeroxidationMaleMiceMice, Inbred C57BLNeuronsNeuroprotective AgentsOrgan Culture TechniquesReceptors, N-Methyl-D-AspartateSynapsesCyclooxygenase 2Neuroprotective AgentsReceptors, N-Methyl-D-Aspartate

Identifiers

PMID21957234
PMCPMC3197234
OpenAlexW1977756329

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.